Sangioza IVS: Financial statements 2017
CVR: 37894532
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
Sangioza IVS (CVR 37894532) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 0 and a net result of DKK 0. Equity in the 2017 report amounted to DKK 2. The solvency ratio was 100%.
- Revenue
- DKK 0
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 0
- Equity
- DKK 2
- Total Assets
- DKK 2
Official annual report
Keep an eye on Sangioza IVS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
Sangioza IVS has published its interim report for the period July 26, 2016 – December 31, 2016.
As of May 21, 2017, Christian Geppel Rasmussen has stepped down as director of Sangioza IVS.
On May 21, 2017, the company changed its name from Creavo IVS to Sangioza IVS.
About Sangioza IVS
Sangioza IVS was a Danish company of the type Iværksætterselskab based in København Ø, founded in 2016. The company has been dissolved on 29 June 2020. The company was registered under the industry Engroshandel med beklædning. The company was previously named Creavo IVS and Stone Designs IVS. In 2019, the company reported a gross profit of DKK -41,216 and a net result of DKK -41,240 compared with DKK -22,943 the year before. Equity in the 2019 report amounted to DKK -64,180.
